NO20004698D0 - Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin - Google Patents

Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin

Info

Publication number
NO20004698D0
NO20004698D0 NO20004698A NO20004698A NO20004698D0 NO 20004698 D0 NO20004698 D0 NO 20004698D0 NO 20004698 A NO20004698 A NO 20004698A NO 20004698 A NO20004698 A NO 20004698A NO 20004698 D0 NO20004698 D0 NO 20004698D0
Authority
NO
Norway
Prior art keywords
quinoxalinones
thrombin
factor
protease inhibitors
serine protease
Prior art date
Application number
NO20004698A
Other languages
English (en)
Other versions
NO20004698L (no
Inventor
Kent Alan Berryman
Dennis Michael Downing
Danette Andrea Dudley
Jeremy John Edmunds
Lakshmi Sourirajan Narasimhan
Stephen Taras Rapundalo
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20004698L publication Critical patent/NO20004698L/no
Publication of NO20004698D0 publication Critical patent/NO20004698D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20004698A 1998-03-31 2000-09-20 Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin NO20004698D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8014298P 1998-03-31 1998-03-31
PCT/US1998/026708 WO1999050257A1 (en) 1998-03-31 1998-12-15 Benzoxazinones/benzothiazinones as serine protease inhibitors

Publications (2)

Publication Number Publication Date
NO20004698L NO20004698L (no) 2000-09-20
NO20004698D0 true NO20004698D0 (no) 2000-09-20

Family

ID=22155527

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004698A NO20004698D0 (no) 1998-03-31 2000-09-20 Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin

Country Status (15)

Country Link
US (2) US6509335B1 (no)
EP (1) EP1068191A1 (no)
JP (1) JP2002509925A (no)
KR (1) KR20010042296A (no)
AU (1) AU765223C (no)
BR (1) BR9815784A (no)
CA (1) CA2319551A1 (no)
HU (1) HUP0101699A3 (no)
IL (1) IL137656A0 (no)
IS (1) IS5590A (no)
NO (1) NO20004698D0 (no)
NZ (1) NZ506985A (no)
PL (1) PL343317A1 (no)
WO (1) WO1999050257A1 (no)
ZA (1) ZA992445B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
EA200100882A1 (ru) * 1999-02-09 2002-04-25 3-Дименшенл Фамэсьютикэлс, Инк. Гетероарильные производные амидина, метиламидина и гуанидина (варианты), способ их получения, фармацевтическая композиция (варианты), способ ингибирования протеазы (варианты) и способ лечения различных заболеваний (варианты)
FR2801885B1 (fr) * 1999-12-06 2002-01-11 Adir Nouveaux derives (dihydro)benzoxaziniques et (dihydro) benzothiaziniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2001057021A2 (en) 2000-02-01 2001-08-09 Cor Therapeutics, Inc. 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
EP1255743A1 (en) * 2000-02-01 2002-11-13 Millenium Pharmaceuticals, Inc. 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
US6998408B2 (en) 2001-03-23 2006-02-14 Bristol-Myers Squibb Pharma Company 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
US6790845B2 (en) 2001-04-09 2004-09-14 Bristol-Myers Squibb Pharma Company Fused heterocyclic inhibitors of factor Xa
US6794385B2 (en) 2001-08-08 2004-09-21 Pharmacia & Upjohn, S.P.A. Benzoxazine derivatives useful as integrin receptor antagonists
US6750215B2 (en) 2001-08-08 2004-06-15 Pharmacia & Upjohn, S.P.A. Substituted benzoxazines as integrin antagonists
US6916398B2 (en) 2001-10-26 2005-07-12 Applied Materials, Inc. Gas delivery apparatus and method for atomic layer deposition
MXPA04006281A (es) * 2001-12-28 2004-09-27 Acadia Pharm Inc Analogos de tetrahidroquinolina como agonistas muscarinicos.
US6759298B2 (en) * 2002-06-24 2004-07-06 Micron Technology, Inc. Methods of forming an array of flash field effect transistors and circuitry peripheral to such array
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
TWI289141B (en) 2003-03-11 2007-11-01 Hoffmann La Roche F. Ag. Quinolinone derivatives and uses thereof
WO2005032471A2 (en) * 2003-10-03 2005-04-14 Merck & Co., Inc. Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
SI21658A (sl) * 2003-11-28 2005-06-30 Univerza V Ljubljani Antitrombotične učinkovine z dualnim mehanizmom delovanja na osnovi 3,4-dihidro-2H-1,4-benzoksazinskega skeleta
KR20070073887A (ko) * 2004-10-12 2007-07-10 그렌마크 파머수티칼스 에스. 아. 신규한 디펩티딜 펩티다제 ⅳ 억제제, 이를 함유하는약제학적 조성물, 및 이의 제조공정
US20080269204A1 (en) * 2004-11-01 2008-10-30 Tatyana Dyakonov Compounds and Methods of Use Thereof
GB0515323D0 (en) * 2005-07-26 2005-08-31 Electrophoretics Ltd Mass labels
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
WO2011024987A1 (ja) * 2009-08-31 2011-03-03 塩野義製薬株式会社 芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
EP2702064A4 (en) * 2011-04-29 2014-10-08 Icahn School Med Mount Sinai Kinase Inhibitors
JP6497808B2 (ja) * 2015-06-12 2019-04-10 アグロカネショウ株式会社 １，４−ベンゾチアジン−１，３−ジオン又は−１，１，３−トリオン誘導体およびこれを有効成分とする殺菌剤
CA3151626A1 (en) 2019-10-01 2021-04-08 Molecular Skin Therapeutics, Inc. Benzoxazinone compounds as klk5/7 dual inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124577A (en) * 1964-03-10 Hydroxyalkyl cyclic amlno
US3006916A (en) * 1961-10-31 W-dialkylaminoalkyl
US3089872A (en) * 1961-03-31 1963-05-14 Olin Mathieson Benzothiazine and benzothiazepine compounds
US3401166A (en) 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
GB1174626A (en) * 1967-05-23 1969-12-17 Bellon Labor Sa Roger New Benzoxazine Derivatives
DE2044530A1 (de) 1970-02-04 1971-08-19 VEB Deutsches Hydrierwerk Rodleben, χ 4530 Roßlau Verfahren zur Herstellung basisch substituierter 2,3 Dihydro 1,4 benzoxazm 3 one
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
JPS5265280A (en) * 1975-11-26 1977-05-30 Squibb & Sons Inc Benzoxadinones and their production
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
JPS60166674A (ja) 1984-02-09 1985-08-29 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
EP0237573B1 (en) 1985-07-29 1992-01-15 Santen Pharmaceutical Co., Ltd. Novel benzothiazine derivatives
JPH01272524A (ja) 1988-04-21 1989-10-31 Japan Found Cancer Res 癌化学療法剤
JP2886570B2 (ja) 1989-09-29 1999-04-26 エーザイ株式会社 縮合ヘテロ環を有する化合物
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
JPH09227561A (ja) 1996-02-21 1997-09-02 Tanabe Seiyaku Co Ltd キサンチン誘導体
CA2271116A1 (en) * 1996-11-13 1998-05-22 Gregory J. Wells Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
ATE336485T1 (de) 1997-05-02 2006-09-15 Schering Ag Substituierte heterocyclen und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
AU765223B2 (en) 2003-09-11
EP1068191A1 (en) 2001-01-17
BR9815784A (pt) 2000-11-21
PL343317A1 (en) 2001-08-13
AU765223C (en) 2004-03-18
AU1918399A (en) 1999-10-18
JP2002509925A (ja) 2002-04-02
ZA992445B (en) 1999-10-01
WO1999050257A1 (en) 1999-10-07
NO20004698L (no) 2000-09-20
CA2319551A1 (en) 1999-10-07
NZ506985A (en) 2003-10-31
KR20010042296A (ko) 2001-05-25
IS5590A (is) 2000-08-18
US6509335B1 (en) 2003-01-21
HUP0101699A3 (en) 2002-05-28
HUP0101699A2 (hu) 2002-04-29
US20030187256A1 (en) 2003-10-02
IL137656A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
NO20004698L (no) Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin
IL137655A0 (en) Quinoxalinones as serine protease inhibitors such as factor xa and thrombin
DE69819349D1 (de) 1-amino-7-isochinolin-derivate als serin protease inhibitoren
NO20012980D0 (no) Proteaseinhibitorer
ATE264339T1 (de) Serine protease inhibitoren
NO992734L (no) Serin-protease inhibitorer
EP1140871A4 (en) THROMBIN OR FACTOR XA INHIBITORS
NO995433D0 (no) Protease-inhibitorer
CY2012007I2 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
NO983688D0 (no) Serin-protease-inhibitorer
PT1086076E (pt) Inibidores de sulfonamida de aspartil protease
NO20011966L (no) Serin-protease-inhibitor
ATE534622T1 (de) Aspartylprotease-inhibitoren
NO20004696L (no) Kinoloner som serinproteaseinhibitorer
ID16105A (id) Inhibitor-inhibitor serin protease
DE59711714D1 (de) Thrombininhibitoren
ATE221080T1 (de) Serine-protease-inhibitoren
NO995435D0 (no) Protease-inhibitorer
NO20011388D0 (no) Hydroksamat-inneholdende cystein- og serinproteasehemmere
NO20025786L (no) Protaseinhibitorer
GB9800817D0 (en) Serine protease inhibitors
NO20025005D0 (no) Proteaseinhibitorer
ATE282629T1 (de) Thrombininhibitoren
NO20032328L (no) Proteaseinhibitorer
AU2001289932A1 (en) Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals